In Q1 2026, Abbott Laboratories reported a modest earnings beat, closed its US$21.00 billion Exact Sciences acquisition to expand in cancer diagnostics, and outlined a new volume-led Nutrition strategy after a 6% sales decline, while continuing to face significant infant formula litigation and regulatory scrutiny. These developments have prompted analysts and commentators to reassess Abbott’s execution risks and diversification benefits, balancing dilution from the Exact Sciences deal…
Is Abbott’s Exact Sciences Deal And Nutrition Pivot Altering The Investment Case For Abbott (ABT)?
Latest from Blog
United States Alternative Protein Ingredients Market Accelerates as Sustainable Nutrition and Plant-Based Innovation Reshape the Food Industry
Rising demand for healthier diets, climate-friendly food systems, and next-generation protein technologies is transforming the U.S. alternative protein ingredients market. Post Views: 3
Sirio unveils nutritional gummies compliant with Australian regulations
Sirio Pharma is launching seven gummy concepts at this week’s Complementary Medicines Australia (CMA) Innovation Day 2026 in Sydney, Australia (May 21). The company notes these gummies are compliant with regulatory standards
High-dose prenatal vitamin D3 linked to better childhood memory, but experts caution results
A new study has found that high-dose vitamin D3 supplementation during pregnancy is positively associated with visual and verbal memory, as well as flexibility among children by the age of 10. The authors
STAT+: Senate Democrats propose adding long-term care benefit to Medicare
WASHINGTON — A group of Senate Democrats is proposing that Medicare cover in-home care, which would create the first new benefit in the program since the Part D retail drug benefit more
How to Talk to Your Kids About Food: 5 Tips for Healthy Eating Habits
Picky eating and mealtime stress? Here are five expert-backed tips to help you talk about food in ways that build healthy habits for life. Post Views: 5